Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas

Journal of Biomedical Optics

Volumn 16, Issue 4, 2011, Pages

  Valentine, Ronan M ^a,b   Brown, C Tom A ^a   Moseley, Harry ^b   Ibbotson, Sally ^b   Wood, Kenny ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Monte Carlo simulations; photobleaching; photodynamic doses; photodynamic therapy; protoporphyrin IX fluorescence; singlet oxygen; superficial basal cell carcinoma

Indexed keywords

BASAL CELL CARCINOMA; MONTE CARLO SIMULATION; PHOTODYNAMIC DOSES; PROTOPORPHYRIN IX FLUORESCENCE; SINGLET OXYGEN;

COMPUTER SIMULATION; FLUORESCENCE; MONTE CARLO METHODS; OPTICAL PROPERTIES; OXYGEN; PHOTOBLEACHING; PLASMONS;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; SINGLET OXYGEN;

ARTICLE; BASAL CELL CARCINOMA; BIOLOGICAL MODEL; BLEACHING; HUMAN; IMAGE QUALITY; METABOLISM; METHODOLOGY; MONTE CARLO METHOD; PHOTOCHEMOTHERAPY; SKIN TUMOR; SPECTROFLUOROMETRY;

AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; HUMANS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; PHANTOMS, IMAGING; PHOTOBLEACHING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SINGLET OXYGEN; SKIN NEOPLASMS; SPECTROMETRY, FLUORESCENCE;

EID: 79953789931     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3562540     Document Type: Article

References (48)

1. T. J. Dougherty, Photodynamic therapy., Photochem Photobiol. 58, 895-900 (1993). 10.1111/j.1751-1097.1993.tb04990.x (Pubitemid 2030512)
2. S. Nonell and R. W. Redmond, On the determination of quantum yields for singlet molecular oxygen photosensitization., J. Photochem. Photobiol. B 22, 171-172 (1994). 10.1016/1011-1344(93)06972-6 (Pubitemid 24075174)
3. K. R. Weishaupt, C. J. Gomer, and T. J. Dougherty, Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor., Cancer Res. 36, 2326-2329 (1976).
4. C. A. Morton, K. E. McKenna, and L. E. Rhodes, Guidelines for topical photodynamic therapy: update., Br. J. Dermatol. 159, 1245-1266 (2008). 10.1111/j.1365-2133.2008.08882.x
5. F. W. Hetzel, S. M. Brahmavar, Q. Chen, S. L. Jacques, M. S. Patterson, B. C. Wilson, and T. C. Zhu, Photodynamic therapy dosimetry., AAPM Report No. 88, Am. Assn. of Physicists in Medicine, Medical Physics Publishing (July 2005).
6. B. C. Wilson, M. S. Patterson, and L. Lilge, Implicit and explicit dosimetry in photodynamic therapy: a new paradigm., Lasers. Med. Sci. 12, 182-199 (1997). 10.1007/BF02765099 (Pubitemid 27404122)
7. T. S. Mang, T. J. Dougherty, W. R. Potter, D. G. Boyle, S. Somer, and J. Moan, Photobleaching of porphyrins used in photodynamic therapy and implications for therapy., Photochem. Photobiol. 45, 501-506 (1987). 10.1111/j.1751-1097. 1987.tb05409.x
8. I. Georgakoudi and T. H. Foster, Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry., Photochem. Photobiol. 67 (6), 612-625 (1998). (Pubitemid 128471939)
9. D. J. Robinson, H. S. de Bruijn, N. Van Der Veen, M. R. Stringer, S. B. Brown, and W. M. Star, Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect., Photochem. Photobiol. 67 (1), 140-149 (1998). 10.1111/j.1751-1097.1998.tb05177.x (Pubitemid 128471972)
10. T. J. Farrell, R. P. Hawkes, M. S. Patterson, and B. C. Wilson, Modeling of photosensitiser fluorescence emission and photobleaching for photodynamic therapy dosimetry., Appl. Opt. 37 (31), 7168-7183 (1998). 10.1364/AO.37.007168 (Pubitemid 128659455)
11. S. K. Chang, N. Marin, M. Follen, and R. Richards-Kortum, Model-based analysis of clinical fluorescence spectroscopy for in vivo detection of cervical intraepithelial dysplasia., J. Biomed. Opt. 11 (2), 024008 (2006).
12. E. Drakaki, M. Makropoulou, and A. A. Serafetinides, In vitro fluorescence measurements and Monte Carlo simulation of laser irradiation propagation in porcine skin tissue., Lasers Med. Sci. 23, 267-276 (2008). 10.1007/s10103-007-0478-2 (Pubitemid 351873598)
13. G. Yoon, A. J. Welch, M. Motamedi, and M. C. J. van Gemert, Development and application of three-dimensional light distribution model for laser irradiated tissue., IEEE J. Quantum Electron. QE-23, 1721-1733 (1987).
14. M. Keijzer, W. M. Star, and P. R. M. Storchi, Optical diffusion in layered media., Appl. Optics. 27, 1820-1824 (1988). 10.1364/AO.27.001820
15. J. Swartling, A. Pifferi, A. M. K. Enejder, and S. Andersson-Engels, Accelerated Monte Carlo models to simulate fluorescence spectra from layered tissues., J. Opt. Soc. Am. A. 20 (4), 714-727 (2003). 10.1364/JOSAA.20.000714
16. M. Keijzer, S. L. Jacques, S. A. Prahl, and A. J. Welch, Light distributions in artery tissue: Monte Carlo simulations for finite-diameter laser beams., Lasers Surg. Med. 9, 148-154 (1989). 10.1002/lsm.1900090210 (Pubitemid 19119404)
17. H. Moseley, Light distribution and calibration of commercial PDT LED arrays., Photochem. Photobiol. Sci. 4, 911-914 (2005). 10.1039/b507325a (Pubitemid 41686583)
18. V. Nadeau, M. O'Dwyer, K. Hamdan, I. Tait, and M. Padgett, In vivo measurement of 5-aminolaevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities., Photodermatol. Photoimmunol. Photomed. 20, 170-174 (2004). 10.1111/j.1600-0781.2004.00100.x (Pubitemid 39077012)
19. L. Wang, S. L. Jacques, and L. Zheng, MCML-Monte Carlo modeling of light transport in multi-layered tissues., Comput. Methods Programs Biomed. 47, 131-146 (1995). 10.1016/0169-2607(95)01640-F
20. A. J. Welch, C. Gardner, R. Richards-Kortum, E. Chan, G. Criswell, J. Pfefer, and S. Warren, Propagation of Fluorescent Light., Lasers Surg. Med. 21, 166-178 (1997). 10.1002/(SICI)1096-9101(1997)21:2166::AID-LSM83.0.CO;2-O (Pubitemid 27335332)
21. M. L. de Jode, Monte Carlo simulations of light distributions in an embedded tumour model: studies of selectivity in photodynamic therapy., Lasers Med. Sci. 15, 49-56 (2000). 10.1007/s101030050047 (Pubitemid 30102794)
22. L. V. Wang, R. E. Nordquist, and W. R. Chen, Optimal beam size for light delivery to absorption-enhanced tumors buried in biological tissues and effect of multiple-beam delivery: a Monte Carlo study., Appl. Opt. 36 (31), 8286-8291 (1997). 10.1364/AO.36.008286 (Pubitemid 127688053)
23. L. G. Henyey and J. L. Greenstein, Diffuse radiation in the galaxy., Anales dAstrophysique 3, 117-137 (1940).
24. K. Wood, J. E. Bjorkman, B. Whitney, and A. D. Code, The effect of multiple scattering on the polarization from axisymmetric circumstellar envelopes. I. pure thomson scattering envelopes., The Astrophysical Journal 461, 828-846 (1996). 10.1086/177105 (Pubitemid 126062016)
25. K. Wood, J. E. Bjorkman, B. Whitney, and A. D. Code, The effect of multiple scattering on the polarization from axisymmetric circumstellar envelopes. II. Thomson scattering in the presence of absorptive opacity sources., The Astrophysical Journal 461, 847-857 (1996). 10.1086/177106 (Pubitemid 126062017)
26. K. Wood and R. J. Reynolds, A model for the scattered light contribution and polarization of the diffuse H galactic background., The Astrophysical Journal 525, 799-807 (1999). 10.1086/307939
27. A. J. L. Jongen and H. J. C. M Sterenborg, Mathematical description of photobleaching in vivo describing the influence of tissue optics on measured fluorescence signals., Phys. Med. Biol. 42, 1701-1716 (1997). 10.1088/0031-9155/42/9/003 (Pubitemid 27400356)
28. M. S. Patterson, B. C. Wilson, and R. Graff, In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminium chlorosulphonated phthalocyanine., Photochem. Photobiol. 51, 343-349 (1990). 10.1111/j.1751-1097.1990.tb01720.x
29. S. L. Jacques, R. Joseph, and G. Gofstein, How photobleaching affects dosimetry and fluorescence monitoring of PDT in turbid media., Proc. SPIE 1881, 168-179 (1993). 10.1117/12.146307
30. E. Salomatina, B. Jiang, J. Novak, and A. N. Yaroslavsky, Optical properties of normal and cancerous human skin in the visible and near-infrared spectral range., J. Biomed. Opt. 11 (6), 064026 (2006).
31. A. N. Bashkatov, E. A. Genina, V. I. Kochubey, and V. V. Tuchin, Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm., J. Phys. D 38, 2543-2555 (2005). 10.1088/0022-3727/38/15/004 (Pubitemid 41067742)
32. E. K. Chan, B. Sorg, D. Protsenko, M. O'Neil, M. Motamedi, and A. J. Welch, Effects of compression on soft tissue optical properties., IEEE J. Quantum Electron 4 (2), 943-950 (1996). (Pubitemid 126543835)
33. M. B. Ericson, C. Sandberg, B. Stenquist, F. Gudmundson, M. Karlsson, A.-M. Ros, A. Rosen, O. Larko, A.-M. Wennberg, and I. Rosdahl, Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome., Br. J. Dermatol. 151, 1204-1212 (2004). 10.1111/j.1365-2133.2004.06211.x (Pubitemid 40030168)
34. W. J. Cottrell, A. D. Paquette, K. R. Keymel, T. H. Foster, and A. R. Oseroff, Irradiance-dependent photobleaching and pain in -aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas., Clin. Cancer Res. 14 (14), 4475-4483 (2008). 10.1158/1078-0432.CCR-07-5199
35. R.-M. Szeimies, C. A. Morton, A. Sidoroff, and L. R. Braathen, Photodynamic therapy for non-melanoma skin cancer., Acta Derm. Venereol. 85, 483-490 (2005). (Pubitemid 43087284)
36. J. Hewitt, V. Nadeau, J. Ferguson, H. Moseley, S. Ibbotson, J. W. Allen, W. Sibbett, and M. Padgett, The application of a compact multispectral imaging system with integrated excitation source to in vivo monitoring of fluorescence during topical photodynamic therapy of superficial skin cancers., Photochem. Photobiol. 73 (3), 278-282 (2001). 10.1562/0031-8655(2001)0730278TAOACM2.0.CO2
37. J. H. Woodhams, A. J. MacRobert, and S. G. Bown, The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry., Photochem. Photobiol. Sci. 6, 1246-1256 (2007). 10.1039/b709644e (Pubitemid 350191109)
38. K. K. Wang, W. J. Cottrell, S. Mitra, A. R. Oseroff, and T. H. Foster, Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT., Lasers Surg. Med. 41, 686-696 (2009). 10.1002/lsm.20847
39. B. W. Henderson, T. M. Busch, L. A. Vaughan, N. P. Frawley, D. Babich, T. A. Sosa, J. D. Zollo, A. S. Dee, M. T. Cooper, D. A. Bellnier, W. R. Greco, and A. R. Oseroff, Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate., Cancer Res. 60, 525-529 (2000). (Pubitemid 30094543)
40. R. M. Valentine, S. H. Ibbotson, C. T. A. Brown, K. Wood, and H. Moseley, A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy., Photochem. Photobiol. 87 (1), 242-249 (2011). 10.1111/j.1751-1097.2010.00829.x
41. B. Kruijt, H. S. de Bruijn, A. Van Der Ploeg-van den Heuvel, R. W. F. de Bruin, H. J. C. M. Sterenborg, A. Amelink, and D. J. Robinson, Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy., Photochem. Photobiol. 84, 1515-1527 (2008). 10.1111/j.1751-1097.2008.00379.x
42. Q. Peng, A. M. Soler, T. Warloe, J. M. Nesland, and K. E. Giercksky, Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate., J. Photochem. Photobiol. B. 62 (3), 140-145 (2001). 10.1016/S1011-1344(01)00173-7 (Pubitemid 32898834)
43. L. O. Svaasand, P. Wyss, M. T. Wyss, Y. Tadir, B. J. Tromberg, and M. W. Berns, Dosimetry model for photodynamic therapy with topically administered photosensitizers., Lasers Surg. Med. 18, 139-149 (1996). 10.1002/(SICI)1096- 9101(1996)18:2139::AID-LSM33.0.CO;2-T (Pubitemid 26063005)
44. A. Johansson, T. Johansson, M. S. Thompson, N. Bendsoe, K. Svanberg, S. Svanberg, and S. Andersson-Engels, In vivo measurement of parameters of dosimetric importance during interstitial photodynamic therapy of thick skin tumors., J. Bio. Opt. 11 (3), 034029 (2006). 10.1117/1.2204027 (Pubitemid 44363260)
45. Q. Peng, T. Warloe, J. Moan, H. Heyerdahl, H. B. Steen, J. M. Nesland and K.-E. Giercksky, Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma., Photochem. Photobiol. 62, 906-913 (1995). 10.1111/j.1751-1097.1995.tb09154.x (Pubitemid 3001597)
46. J. D. Vollet-Filho, P. F. C. Menezes, L. T. Moriyama, C. Grecco, C. Sibata, R. R. Allison, O. Castro e Silva, and V. S. Bagnato, Possibility for a full optical determination of photodynamic therapy outcome., J. Appl. Phys. 105, 2038-1-2038-7 (2009). 10.1063/1.3116610
47. A. R. Oseroff, S. Shieh, N. P. Frawley, R. Cheney, L. E. Blumenson, E. K. Pivnick, and D. A. Bellnier, Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy., Arch. Dermatol. 141, 60-67 (2005). 10.1001/archderm.141.1.60 (Pubitemid 40144441)
48. S. Grapengiesser, F. Gudmundsson, O. Larko, M. Ericson, A. Rosen, and A.-M. Wennberg, Pain caused by photodynamic therapy of skin cancer., Clin. Exp. Dermatol. 27, 493-497 (2002). 10.1046/j.1365-2230.2002.01065.x (Pubitemid 35278943)